Cargando…

Single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: A protocol of systematic review and meta-analysis

BACKGROUND: The evidence related to bleeding and thromboembolic events after transcatheter aortic valve replacement (TAVR) compared single antiplatelet therapy (SAPT) with dual antiplatelet therapy (DAPT) treatment are inconsistent. Moreover, there are some limitations such as small sample size and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongyan, Wang, Yafeng, Li, Longyu, Dan, Bao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886480/
https://www.ncbi.nlm.nih.gov/pubmed/33578550
http://dx.doi.org/10.1097/MD.0000000000024550
_version_ 1783651803604189184
author Li, Hongyan
Wang, Yafeng
Li, Longyu
Dan, Bao
author_facet Li, Hongyan
Wang, Yafeng
Li, Longyu
Dan, Bao
author_sort Li, Hongyan
collection PubMed
description BACKGROUND: The evidence related to bleeding and thromboembolic events after transcatheter aortic valve replacement (TAVR) compared single antiplatelet therapy (SAPT) with dual antiplatelet therapy (DAPT) treatment are inconsistent. Moreover, there are some limitations such as small sample size and the risk of bias in existing studies. We will conduct a comprehensive systematic review and meta-analysis to explore the safety and efficacy of SAPT or DAPT after TAVR. METHODS: A comprehensive literature search of PubMed, EMBASE, The Cochrane Library, Cochrane Central Register of Controlled Trials will be searched to retrieve studies involving SAPT versus DAPT after TAVR. Two investigators will independently select studies, extract data, and assess the quality of the included study. Any disagreement will be resolved by the third investigator. The study will use a random-effects model to pool the results of all studies and use the relative risk and 95% confidence intervals to summarize individual trial outcomes and estimate pooled effect. The study will use the Grading of Recommendations Assessment, Development, and Evaluation to assess the certainty of evidence. RESULTS: This study will provide high-quality evidence for treatment of TAVR in terms of effectiveness and safety. CONCLUSION: This systematic review aims to provide evidence for treatment of TAVR in different antiplatelet therapies. REGISTRATION: The systematic review and meta-analysis is registered in the OSF REGISTRIES (10.17605/OSF.IO/Q42TE) international prospective register.
format Online
Article
Text
id pubmed-7886480
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78864802021-02-18 Single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: A protocol of systematic review and meta-analysis Li, Hongyan Wang, Yafeng Li, Longyu Dan, Bao Medicine (Baltimore) 3400 BACKGROUND: The evidence related to bleeding and thromboembolic events after transcatheter aortic valve replacement (TAVR) compared single antiplatelet therapy (SAPT) with dual antiplatelet therapy (DAPT) treatment are inconsistent. Moreover, there are some limitations such as small sample size and the risk of bias in existing studies. We will conduct a comprehensive systematic review and meta-analysis to explore the safety and efficacy of SAPT or DAPT after TAVR. METHODS: A comprehensive literature search of PubMed, EMBASE, The Cochrane Library, Cochrane Central Register of Controlled Trials will be searched to retrieve studies involving SAPT versus DAPT after TAVR. Two investigators will independently select studies, extract data, and assess the quality of the included study. Any disagreement will be resolved by the third investigator. The study will use a random-effects model to pool the results of all studies and use the relative risk and 95% confidence intervals to summarize individual trial outcomes and estimate pooled effect. The study will use the Grading of Recommendations Assessment, Development, and Evaluation to assess the certainty of evidence. RESULTS: This study will provide high-quality evidence for treatment of TAVR in terms of effectiveness and safety. CONCLUSION: This systematic review aims to provide evidence for treatment of TAVR in different antiplatelet therapies. REGISTRATION: The systematic review and meta-analysis is registered in the OSF REGISTRIES (10.17605/OSF.IO/Q42TE) international prospective register. Lippincott Williams & Wilkins 2021-02-12 /pmc/articles/PMC7886480/ /pubmed/33578550 http://dx.doi.org/10.1097/MD.0000000000024550 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 3400
Li, Hongyan
Wang, Yafeng
Li, Longyu
Dan, Bao
Single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: A protocol of systematic review and meta-analysis
title Single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: A protocol of systematic review and meta-analysis
title_full Single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: A protocol of systematic review and meta-analysis
title_fullStr Single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: A protocol of systematic review and meta-analysis
title_full_unstemmed Single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: A protocol of systematic review and meta-analysis
title_short Single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: A protocol of systematic review and meta-analysis
title_sort single- or dual-antiplatelet therapy after transcatheter aortic valve replacement: a protocol of systematic review and meta-analysis
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886480/
https://www.ncbi.nlm.nih.gov/pubmed/33578550
http://dx.doi.org/10.1097/MD.0000000000024550
work_keys_str_mv AT lihongyan singleordualantiplatelettherapyaftertranscatheteraorticvalvereplacementaprotocolofsystematicreviewandmetaanalysis
AT wangyafeng singleordualantiplatelettherapyaftertranscatheteraorticvalvereplacementaprotocolofsystematicreviewandmetaanalysis
AT lilongyu singleordualantiplatelettherapyaftertranscatheteraorticvalvereplacementaprotocolofsystematicreviewandmetaanalysis
AT danbao singleordualantiplatelettherapyaftertranscatheteraorticvalvereplacementaprotocolofsystematicreviewandmetaanalysis